文章摘要
张廷 洪燕.复方丹参滴丸对心血瘀阻证冠心病临床研究[J].实用中西医结合临床,2003,(6):3-4
复方丹参滴丸对心血瘀阻证冠心病临床研究
  
DOI:
中文关键词: 冠心病  中西医结合疗法  复方丹参滴丸  硝酸酯类  β-阻滞剂  钙离子拮抗剂  肠溶阿斯匹林
英文关键词: Coronary Heart disease  FuFang DanShen diwan
基金项目:
作者单位
张廷 洪燕 武警江西总队医院 
摘要点击次数: 670
全文下载次数: 327
中文摘要:
      目的:评价复方丹参滴丸治疗冠心病心血瘀阻证患者的临床疗效。方法:冠心病患者100例随机分为常规治疗组(对照组)和常规治疗加复方丹参滴丸组(治疗组),疗程均为4周。结果:4周后总有效率,治疗组与对照组分别为85%、70%(P<0.05),治疗组全血粘度、血浆粘度、全血还原粘度及血小板聚集率均明显降低(P<0.01),血总胆固醇、甘油三酯及低密度脂蛋白明显下降,高密度脂蛋白升高(P<0.05);观察随访半年,治疗组心血管事件发生率明显低于对照组(10%对20%,P<0.05)。结论:在常规治疗基础上加用复方丹参滴丸能降低血粘度,改善脂质代谢,能有效地控制心绞痛发作,减少心血管事件发生率。
英文摘要:
      Objective:To evaluate clincal effect of FuFang DanShen diwan (DSP) on patients with Coronary Heart disease(CHD).MOTHODS:100 cases of CHD were randomly divided into the control group (of normal treatment) and the treating group(normal treatment combined with DSP).The therapeutic couse was four weeks.Results: The effective rate was 85% in treating group and 70% in the control group after four weeks (P<0.05). Total blood viscosity, plasma viscosity, total blood reductive viscosity and platelet aggregation rate in the treating group were signifivantly decreased (P<0.01).Serum total cholesterol triglyceride and LDL-ch in the treating group were signigicantly lowered (P<0.05).HDL-ch were risen.The incidences of cardiac event were signigicantly lower in the treating group than in the control group( 10% v 20%,P<0.05).Conclusion: DSP combined with normal treatment can control angina pectoris effectively and decrease incidence of cardiac event.
查看全文   查看/发表评论  下载PDF阅读器
关闭
手机扫一扫看
分享按钮